Citation Impact
Citing Papers
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
A Multicenter Study of Recombinant Factor VIII (Recombinate): Safety, Efficacy, and Inhibitor Risk in Previously Untreated Patients With Hemophilia A
1994
Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles
2020
Thrombophilia and its impact on pregnancy
2009
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
2000
Mechanisms of Thrombus Formation
2008 Standout
Delayed graft function in kidney transplantation
2004 Standout
Cerebral venous thrombosis: an update
2007 Standout
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family
2002
Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort study
2007
Lipid nanoparticles for mRNA delivery
2021 Standout
Childhood acute lymphoblastic leukaemia – current status and future perspectives
2001
In utero stem cell transplantation and gene therapy: rationale, history, and recent advances toward clinical application
2016
Antithrombotic Therapy for VTE Disease
2016 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
2006
The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin Mutation
1999
Vascular disorders of the liver # †
2008 Standout
Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's Disease
2001 Standout
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Host genetic determinants of Neisseria meningitidis infections
2003
Prothrombotic abnormalities in childhood ischaemic stroke
2005
Pegaspargase: a review of clinical studies
2003
Antithrombotic Therapy for VTE Disease
2012 Standout
Aptamers as therapeutics
2010 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Cardiovascular Risk Factors and Venous Thromboembolism Incidence
2002
High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
1998 StandoutNobel
The genetics of venous and arterial thromboembolism
2001
Executive Summary
2012 Standout
Sinovenous thrombosis in children
2003
Use of Antithrombotic Agents During Pregnancy
2004
Aptamers as targeted therapeutics: current potential and challenges
2016 Standout
Perspectives for a vaccine against hepatitis C virus
1999 StandoutNobel
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Factor IX Inhibitors and Anaphylaxis in Hemophilia B
1997
Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of Inhibitors
1993
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Going from evidence to recommendations
2008 Standout
Obesity and Cardiovascular Disease
2009 Standout
Pre-eclampsia
2010 Standout
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
2008
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis
2001
Antithrombotic Therapy in Neonates and Children
2008
Antithrombotic Therapy in Neonates and Children
2012
Cerebral sinus venous thrombosis in children
2004
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
2008 Standout
Outcome of Kidney Transplantation in Patients with Inherited Thrombophilia
2003
Thrombophilia in pregnancy: a systematic review
2005
Immunogenicity of protein therapeutics
2007
Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA)
2006
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study
2000
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
The molecular mechanisms of immunomodulation and tolerance induction to factor VIII
2009
Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside
2003
Factor V Leiden: A Clinical Review
2001
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism
2003
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Development of Albumin-Binding Camptothecin Prodrugs Using a Peptide Positional Scanning Library
2007
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions
2003
Multiple risk factors in neonatal sinovenous thrombosis
2002
Synthesis, Cleavage Profile, and Antitumor Efficacy of an Albumin‐Binding Prodrug of Methotrexate that is Cleaved by Plasmin and Cathepsin B
2007
Guidelines for the Primary Prevention of Stroke
2014 Standout
Parenchymal abnormalities associated with cerebral venous sinus thrombosis: assessment with diffusion-weighted MR imaging.
2005
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Diagnosis and Management of Cerebral Venous Thrombosis
2011 Standout
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
2004 Standout
Cationic microparticles are a potent delivery system for a HCV DNA vaccine
2004 StandoutNobel
Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study
2000
IEDB-AR: immune epitope database—analysis resource in 2019
2019
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
The Epidemiology of Venous Thromboembolism
2003 Standout
Cerebral Venous Thrombosis in Children
2001
Cerebral venous thrombosis
2004
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
2006
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction
1993
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial.
1997
Works of S. Ehrenforth being referenced
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa
2014
Multicentre evaluation of combined prothrombotic defects associated with thrombophilia in childhood
1999
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs
1992
Cerebral venous sinus thrombosis in infancy and childhood: role of genetic and acquired risk factors of thrombophilia
1998
Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII
1995
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden
2000
Combined therapy in human immunodeficiency virus-infected children —a 4-year experience
1993
The course of fibrinolytic proteins in children with malignant bone tumours
1999
APC-Resistenz und venöse Thrombophilie: Molekulargenetische Prävalenzstudie in der deutschen Bevölkerung
2008
Prospective Evaluation of the Thrombotic Risk in Children With Acute Lymphoblastic Leukemia Carrying the MTHFR TT 677 Genotype, the Prothrombin G20210A Variant, and Further Prothrombotic Risk Factors
1999
Study of the Prothrombin Gene 20201 GA Variant in FV:Q 506 Carriers in Relationship to the Presence or Absence of Juvenile Venous Thromboembolism
1999
The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism
2003
Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism
2000
Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia
1999
The Prothrombin 20210 A Allele Is Frequently Coinherited in Young Carriers of the Factor V Arg 506 to Gln Mutation With Venous Thrombophilia
1998
Protease levels in breast, ovary, and other gynecological tumor tissues: prognostic importance in breast cancer.
1997